Define Ownership Without Ambiguity
Clarify which party performs, reviews, approves and remains accountable for every critical GxP activity.
Development, review, negotiation support and remediation of GxP quality agreements for pharmaceutical, biotechnology, clinical research, manufacturing, laboratory, pharmacovigilance and technology relationships requiring clear responsibilities, communication, escalation and regulatory accountability.
A quality agreement should do more than repeat contractual language. It should provide a practical operating framework for quality responsibilities, oversight, notifications, records, decisions, escalation and lifecycle management.
Clarify which party performs, reviews, approves and remains accountable for every critical GxP activity.
Define what must be reported, to whom, within what timeframe and through which documented communication pathway.
Establish access to information, performance data, records, audits, inspections and evidence needed for effective oversight.
Quality agreements become ineffective when they are generic, disconnected from operational workflows or unclear about notifications, evidence, decision rights and escalation.
Both parties assume the other owns a critical task, or both attempt to control the same decision without a defined final authority.
Terms such as “promptly” or “as required” do not provide usable timelines for deviations, changes, inspections or data concerns.
Different documents contain inconsistent responsibilities, access rights, timelines or termination requirements.
Changes in services, systems, subcontractors, sites or regulations are not reflected in the agreement.
Support can address one critical agreement, a portfolio of existing relationships or development of a complete quality-agreement governance model.
Development of practical, relationship-specific agreements aligned with delegated activities, applicable GxP requirements and the organization’s oversight model.
Independent review of existing agreements for missing, conflicting, unclear or impractical responsibilities.
Structured allocation of activities, review responsibilities, approval authority, evidence and escalation ownership.
Quality and compliance support during negotiation with vendors, sponsors, manufacturers, laboratories and strategic partners.
Risk-based review and updating of outdated, incomplete or inconsistent agreements across a vendor or partner portfolio.
Development of procedures and controls for approval, review, amendment, periodic reassessment and termination.
Quality agreements should be aligned with the governing commercial contract and reviewed with appropriate legal counsel. This service focuses on GxP responsibilities, operational controls and quality oversight and does not replace legal advice.
The agreement structure is adapted to the services, regulated activities, data, systems, products, studies, geography and oversight model involved.
Not every agreement requires every provision. Scope should reflect the delegated activity, quality risk, regulatory exposure and relationship complexity.
Quality agreements should be developed and maintained as controlled operational documents throughout the relationship.
Define services, activities, products, systems, sites, records and regulated responsibilities.
Assign ownership, review, approval, notification and escalation responsibilities.
Reconcile the quality agreement with commercial terms, procedures and operational workflows.
Communicate responsibilities, establish governance and integrate the agreement into daily operations.
Review performance, changes and relationship scope and update the agreement when required.
The process combines service review, stakeholder interviews, responsibility mapping, risk analysis, drafting and implementation planning.
Understand the services, products, studies, systems, sites, subcontractors, records and intended operating model.
Review commercial terms, service descriptions, procedures, existing matrices and related agreements.
Map activities, interfaces, decision rights, notifications, records and regulatory accountabilities.
Develop clear, practical clauses aligned with the relationship and identified quality risks.
Resolve operational, quality and legal interfaces and document agreed responsibilities.
Support approval, communication, training, governance, periodic review and future amendments.
Deliverables are tailored to whether the organization requires one agreement, a controlled template suite or a portfolio-wide remediation program.
Support can be provided before contract execution, during active service delivery or when audit findings and operational disputes reveal unclear responsibilities.
A CRO, manufacturer, laboratory or technology provider will perform material GxP activities.
Services have begun without a formal document defining quality and compliance responsibilities.
Services, systems, sites or responsibilities have changed since the agreement became effective.
Auditors identify unclear responsibilities, weak notifications or insufficient partner oversight.
Operational teams disagree about who investigates, approves, notifies or retains evidence.
A large number of vendor agreements are incomplete, inconsistent or overdue for review.
Existing agreements require harmonization, assignment or renegotiation after organizational change.
Services, data, systems and records must be transferred under controlled conditions.
A practical quality agreement gives both parties a common operating model for quality responsibilities, oversight, communication and resolution of critical issues.
Reduce disputes and operational delays by assigning each critical activity to an identified owner.
Establish specific notification timelines and decision pathways for quality and compliance concerns.
Demonstrate documented rights, responsibilities, review, challenge and regulatory support across the relationship.
Common questions from quality, legal, procurement, clinical, manufacturing, laboratory and vendor-management teams.
Yes. The agreement can be developed from the service scope, GxP activities, operational workflows, contractual structure and risk profile of the relationship.
Yes. The review can identify missing responsibilities, weak notifications, conflicting clauses, inadequate audit rights and operationally impractical requirements.
Yes. Support can include development of quality positions, clause review, responsibility clarification and risk-based escalation of unresolved issues.
Yes. The documents should be consistent in scope, responsibilities, access rights, communication, liability interfaces and termination provisions.
Yes. Agreements can be inventoried, risk-ranked, reviewed against a standard framework and updated through a controlled remediation program.
Yes. Document review, stakeholder interviews, responsibility mapping, drafting, negotiation support and governance development can be delivered remotely or through a hybrid model.